LifeTech Scientific Corporation
LifeTech Scientific Corporation (LFTSF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lftsf · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for LifeTech Scientific Corporation (LFTSF) measures how much investors pay for each dollar of the company's trailing earnings. LFTSF's current PE ratio of 44.71x is calculated by dividing its stock price of $0.20 by its TTM earnings per share of $0.03. −6.6% discount vs 5Y avg 47.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2010 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 13 fiscal years · Front-end computedMinQ1 · 25%124.0x
MedianQ3 · 75%7152.5x
Max
At 44.71x, LFTSF's current P/E is lower than in 23% of its annual fiscal year readings over the past 13 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
LifeTech Scientific CorporationYou LFTSF | $858M | 44.71x | +57.1% | $0.03 |
 Arjo AB (publ) ARRJF | $891M | 25.18x | -11.5% | $1.23 |
 EL.En. S.p.A. ELEAF | $760M | 19.67x | -30.9% | $0.54 |
 Extendicare Inc. EXETF | $2.1B | 18.86x | -33.7% | $1.13 |
 Nanosonics Limited NNCSF | $619M | 52.39x | +84.2% | $0.07 |
 Panamera Holdings Corporation PHCI | $188M | N/A | — | -$0.01 |
 RHON-KLINIKUM AG Unsponsored ADR RKAGY | $1.1B | 26.15x | -8.1% | $0.25 |
Industry Average 5 peers with valid PE | — | 28.45x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | 33.56x | $0.05 | +31.0% | |
2023-12-31 FY2023 | 25.62x | $0.06 | -16.0% | |
2022-12-31 FY2022 | 30.51x | $0.08 | -52.6% | |
2021-12-31 FY2021 | 64.41x | $0.06 | -24.3% | |
2020-12-31 FY2020 | 85.14x | $0.05 | -41.3% | |
2019-12-31 FY2019 | 145.01x | $0.03 | -9.4% | |
2018-12-31 FY2018 | 159.98x | $0.03 | +43.0% | |
2017-12-31 FY2017 | 111.89x | $0.04 | -9.8% | |
2016-12-31 FY2016 | 124.02x | $0.04 | -98.3% | |
2015-12-31 FY2015 | 7152.48x | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for LifeTech Scientific Corporation (LFTSF) measures how much investors pay for each dollar of the company's trailing earnings. LFTSF's current PE ratio of 44.71x is calculated by dividing its stock price of $0.20 by its TTM earnings per share of $0.03.
Frequently asked questions
LFTSF pe ratio · 6 questionsLFTSF's current PE ratio is 44.71x as of 2026-06-09, based on a stock price of $0.20 and TTM EPS of $0.03. Data sourced from Financial Modeling Prep via LFTSF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · LifeTech Scientific Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09